Comparative Pharmacology
Head-to-head clinical analysis: FREAMINE 8 5 versus FREAMINE II 8 5.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FREAMINE 8 5 versus FREAMINE II 8 5.
FREAMINE 8.5% vs FREAMINE II 8.5%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
FREAMINE 8.5% is a crystalline amino acid solution that provides essential and nonessential amino acids for protein synthesis, maintenance of nitrogen balance, and tissue repair in patients unable to tolerate oral or enteral nutrition.
FREAMINE II 8.5% is a crystalline amino acid solution that provides essential and non-essential amino acids for protein synthesis, supporting nitrogen balance and tissue repair in patients unable to tolerate oral or enteral nutrition.
1 to 2 g/kg/day intravenously, typical adult dose 70-140 g/day (800-1650 mL of 8.5% solution), infused at a rate not exceeding 0.1 g/kg/hour
Intravenous infusion: 0.8-1.5 g amino acids/kg/day. Typical dose is 500-1000 mL per day (42.5-85 g amino acids). Infusion rate should not exceed 0.1 g amino acids/kg/hour.
None Documented
None Documented
The terminal elimination half-life of infused amino acids is not conventionally defined as it depends on metabolic utilization. For most amino acids, plasma clearance is rapid (minutes to hours) with a pseudo-half-life of approximately 15-30 minutes for the initial distribution phase. Clinical context: half-life is irrelevant since amino acids are continuously metabolized and incorporated into proteins.
Not applicable as a mixture; individual amino acids have variable half-lives (e.g., essential amino acids ~1-3 hours). Clinical context: continuous infusion required to maintain plasma levels.
Amino acids from FREAMINE 8.5% are primarily metabolized via deamination and transamination pathways, with nitrogen waste excreted renally as urea (approx 80-90% of administered nitrogen). A small fraction is excreted via feces as unabsorbed amino acids (less than 5%). Biliary excretion is negligible.
Renal elimination of nitrogenous waste products (urea) derived from amino acid metabolism; <5% excreted unchanged in urine. No significant biliary or fecal elimination.
Category C
Category C
Parenteral nutrition amino acid
Parenteral nutrition amino acid